This trial is conducted in Europe. The aim of this clinical trial is to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of a NNC126-0083 in healthy male Japanese subjects.

Inclusion Criteria:

• Healthy male subjects with Japanese passport and Japanese born parents
• Body Mass Index (BMI, kg/m2) between 18.0 and 27.0, both inclusive
• Subjects must be in good health according to age

Exclusion Criteria:

• A history or presence of cancer, diabetes, or any clinically significant cardiovascular, respiratory, metabolic, renal, hepatic, gastrointestinal, endocrinological, haematological, dermatological, venereal, neurological, psychiatric diseases or other major diseases
• History of any illnesses or disease that, in the opinion of the Investigator might confound the results of the trial or pose additional risk in administering the trial product to the subject
• Any clinically significant abnormal haematology, biochemistry or urinalysis screening tests, as judged by the Investigator